StoneX Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Buy
+930
New +$259K 0.01% 1208
2023
Q2
– Sell
-513
Closed -$50.4K – 694
2023
Q1
$50.4K Buy
+513
New +$69.6K 0.01% 582

Other funds holding LABU

StoneX Group's LABU Position: Q3 2026 in Review

StoneX Group opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2026: 930 shares worth $241K. The stake represents 0.01% of the portfolio and ranks #1208 among its holdings. This is a return to the name: StoneX Group previously reported a position in LABU as recently as Q1 2023.

StoneX Group first reported a position in LABU in Q1 2023 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

  • StoneX Group held 930 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $241K as of Q3 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new StoneX Group position in Q3 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.01% of StoneX Group's portfolio in Q3 2026, its #1208 holding.
  • StoneX Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.